Smart Molding International 2-2024

11 www.smart-molding.com newsfeed before eventually venturing into plastic injection and blow molding. Comar’s success is rooted in its unique approach to problem-solving, which comb i ne s f re sh t h i nk i ng , engineering expertise, and a relentless focus on client satisfaction. Brian Larkin, President and CEO of Comar, reflects on the company’s journey, stating, “In all its iterations through all the years, Comar has continuously evolved and adapted to meet the changing needs of its clients, providing innovative design solutions and quality-driven manufacturing to drive progress and shape the future of packaging and medical solutions.” “Our success today is a testament to the enduring values instilled in our organization, stemming from our rich family heritage and unwavering commitment to our long-standing hea l t hca re c l i ente l e . F rom ou r beginnings as a family business to our current status as a premier global supplier, Comar’s journey reflects the resilience of our core values and the strength of our partnerships.” Added Comar Chairman, Mike Ruggieri. As part of its anniversary celebration, Comar reaffirms its commitment to innovation, progress, and collaboration. “Together, we set progress in motion,” emphasizes Larkin. “As we look ahead to the next 75 years, we remain dedicated to driving innovation, exceeding expectations, and making a difference in the lives of our clients and the communities we serve.” Comar www.comar.com Photo: Arkema DuPont has acquired Donatelle Plastics Incorporated DuPont has completed the previously announced acquisition of Donatelle Plastics, a leading medical device contract manufacturer specializing in medical components and devices. The acquisition of Donatelle brings complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building. “Our healthcare strategy is focused on offering a comprehensive suite of solutions for customers in high-growth therapeutic areas,” said Jon Kemp, President, DuPont Electronics & Industrial (E&I). “Donatelle Plastics Incorporated will be the second acquisition, following Spectrum last year, that will deepen our expertise in the medical device market segments and enhance our position as a partner of choice for our customers.” DuPont’s healthcare exposure within the Industrial Solutions line of business of the E&I segment includes Spectrum, a leader inmedical device components, and Liveo™, a leader in silicone solutions for healthcare applications. The acquisition of Donatelle Plastics Incorporated will bring complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building. Donatelle Plastics Incorporated has a strong financial growth profile aligned to attractive therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities. Founded in 1967 and headquartered in New Brighton, Minnesota, Donatelle Plastics Incorporated has a workforce of more than 400 employees and operates a facility strategically located in a medical technologies hub near leading original equipment manufacturers. Donatelle Plastics Incorporated has established decades-long relationships by providing best-in-class customer service, top-notch quality and injection molding expertise. They are recognized for innovation in medical device and component manufacturing, particularly in complex applications where quality, reliability and technical expertise is required for critical end-use applications. “We’re excited for this next chapter in Donatelle’s journey and for our team of highly talented and skilled employees to join DuPont,” said Treasa Springett, President of Donatelle Plastics Incorporated. “As a part of a broader healthcare offering, we will have even greater impact on patient outcomes by enabling the innovation and development of next generation devices for patients worldwide.” DuPont www.dupont.com. Picture: Comar Picture: DuPont